Ignite Creation Date:
2025-12-24 @ 3:16 PM
Ignite Modification Date:
2026-01-24 @ 8:23 PM
Study NCT ID:
NCT02303392
Status:
COMPLETED
Last Update Posted:
2025-06-10
First Post:
2014-11-25
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Selinexor and Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Aggressive Non-Hodgkin Lymphoma
Sponsor:
Organization: